|
1
|
Belot A, Kasher PR, Trotter EW, Foray AP,
Debaud AL, Rice GI, Szynkiewicz M, Zabot MT, Rouvet I, Bhaskar SS,
et al: Protein kinase cδ deficiency causes mendelian systemic lupus
erythematosus with B cell-defective apoptosis and
hyperproliferation. Arthritis Rheum. 65:2161–2171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahman A and Isenberg DA: Systemic lupus
erythematosus. N Engl J Med. 358:929–939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anolik JH: B cell biology and dysfunction
in SLE. Bull NYU Hosp Jt Dis. 65:182–186. 2007.PubMed/NCBI
|
|
4
|
Furukawa F: Animal models of cutaneous
lupus erythematosus and lupus erythematosus photosensitivity.
Lupus. 6:193–202. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen PL and Eisenberg RA: Lpr and gld:
Single gene models of systemic autoimmunity and lymphoproliferative
disease. Annu Rev Immunol. 9:243–269. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Favaloro B, Allocati N, Graziano V, Di
Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging
(Albany, NY). 4:330–349. 2012. View Article : Google Scholar
|
|
7
|
Reed JC: Molecular biology of chronic
lymphocytic leukemia. Semin Oncol. 25:11–18. 1998.PubMed/NCBI
|
|
8
|
Zhang Y, Dawson MI, Mohammad R, Rishi AK,
Farhana L, Feng KC, Leid M, Peterson V, Zhang XK, Edelstein M, et
al: Induction of apoptosis of human B-CLL and ALL cells by a novel
retinoid and its nonretinoidal analog. Blood. 100:2917–2925. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitada S, Andersen J, Akar S, Zapata JM,
Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, et
al: Expression of apoptosis-regulating proteins in chronic
lymphocytic leukemia: Correlations with In vitro and In vivo
chemoresponses. Blood. 91:3379–3389. 1998.PubMed/NCBI
|
|
10
|
Burz C, Berindan-Neagoe I, Balacescu O and
Irimie A: Apoptosis in cancer: Key molecular signaling pathways and
therapy targets. Acta Oncol. 48:811–821. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jazirehi AR: Regulation of
apoptosis-associated genes by histone deacetylase inhibitors:
Implications in cancer therapy. Anticancer Drugs. 21:805–813. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neznanov N, Komarov AP, Neznanova L,
Stanhope-Baker P and Gudkov AV: Proteotoxic stress targeted therapy
(PSTT): Induction of protein misfolding enhances the antitumor
effect of the proteasome inhibitor bortezomib. Oncotarget.
2:209–221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eberhard Y, Gronda M, Hurren R, Datti A,
MacLean N, Ketela T, Moffat J, Wrana JL and Schimmer AD: Inhibition
of SREBP1 sensitizes cells to death ligands. Oncotarget. 2:186–196.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goldberg AA, Beach A, Davies GF, Harkness
TA, Leblanc A and Titorenko VI: Lithocholic bile acid selectively
kills neuroblastoma cells, while sparing normal neuronal cells.
Oncotarget. 2:761–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vincent FB, Morand EF and Mackay F: BAFF
and innate immunity: New therapeutic targets for systemic lupus
erythematosus. Immunol Cell Biol. 90:293–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vincent FB, Morand EF, Schneider P and
Mackay F: The BAFF/APRIL system in SLE pathogenesis. Nat Rev
Rheumatol. 10:365–373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma N, He Y, Xiao H, Han G, Chen G, Wang Y,
Wang K, Hou C, Yang X, Marrero B, et al: BAFF maintains T-cell
survival by inducing OPN expression in B cells. Mol Immunol.
57:129–137. 2014. View Article : Google Scholar
|
|
18
|
Moon EY, Yi KY and Lee S: An increase in B
cell apoptosis by interfering BAFF-BAFF-R interaction with small
synthetic molecules. Int Immunopharmacol. 11:1523–1533. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nestorov I, Munafo A, Papasouliotis O and
Visich J: Pharmacokinetics and biological activity of atacicept in
patients with rheumatoid arthritis. J Clin Pharmacol. 48:406–417.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma N, Xing C, Xiao H, He Y, Han G, Chen G,
Hou C, Marrero B, Wang Y, Zhang S, et al: BAFF suppresses IL-15
expression in B cells. J Immunol. 192:4192–4201. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carbonatto M, Yu P, Bertolino M, Vigna E,
Steidler S, Fava L, Daghero C, Roattino B, Onidi M, Ardizzone M, et
al: Nonclinical safety, pharmacokinetics, and pharmacodynamics of
atacicept. Toxicol Sci. 105:200–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang S, Li JY and Xu W: Role of
BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma. Crit Rev Oncol
Hematol. 91:113–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wild J, Schmiedel BJ, Maurer A, Raab S,
Prokop L, Stevanović S, Dörfel D, Schneider P and Salih HR:
Neutralization of (NK-cell-derived) B-cell activating factor by
Belimumab restores sensitivity of chronic lymphoid leukemia cells
to direct and Rituximab-induced NK lysis. Leukemia. 29:1676–1683.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma N, Liu X, Xing C, Wang X, Wei Y, Han G,
Chen G, Hou C, Shen B, Li Y, et al: Ligation of metabotropic
glutamate receptor 3 (Grm3) ameliorates lupus-like disease by
reducing B cells. Clin Immunol. 160:142–154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rieger AM, Nelson KL, Konowalchuk JD and
Barreda DR: Modified annexin V/propidium iodide apoptosis assay for
accurate assessment of cell death. J Vis Exp.
50:25972011.PubMed/NCBI
|
|
26
|
Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han
G, Chen G, Hou C, Ma N, Shen B, et al: A novel IL-23p19/Ebi3
(IL-39) cytokine mediates inflammation in Lupus-like mice. Eur J
Immunol. 46:1343–1350. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawahara T, Kashiwagi E, Ide H, Li Y,
Zheng Y, Ishiguro H and Miyamoto H: The role of NFATc1 in prostate
cancer progression: Cyclosporine A and tacrolimus inhibit cell
proliferation, migration, and invasion. Prostate. 75:573–584. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee JW, Chen H, Pullikotil P and Quon MJ:
Protein kinase A-alpha directly phosphorylates FoxO1 in vascular
endothelial cells to regulate expression of vascular cellular
adhesion molecule-1 mRNA. J Biol Chem. 286:6423–6432. 2011.
View Article : Google Scholar
|
|
29
|
Long JS and Ryan KM: New frontiers in
promoting tumour cell death: Targeting apoptosis, necroptosis and
autophagy. Oncogene. 31:5045–5060. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Horwacik I and Rokita H: Targeting of
tumor-associated ganglio-sides with antibodies affects signaling
pathways and leads to cell death including apoptosis. Apoptosis.
20:679–688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kandaswamy R, McQuillin A, Sharp SI,
Fiorentino A, Anjorin A, Blizard RA, Curtis D and Gurling HM:
Genetic association, mutation screening, and functional analysis of
a Kozak sequence variant in the metabotropic glutamate receptor 3
gene in bipolar disorder. JAMA Psychiatry. 70:591–598. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prickett TD, Wei X, Cardenas-Navia I, Teer
JK, Lin JC, Walia V, Gartner J, Jiang J, Cherukuri PF, Molinolo A,
et al: Exon capture analysis of G protein-coupled receptors
identifies activating mutations in GRM3 in melanoma. Nat Genet.
43:1119–1126. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zambon AC, Wilderman A, Ho A and Insel PA:
Increased expression of the pro-apoptotic protein BIM, a mechanism
for cAMP/protein kinase A (PKA)-induced apoptosis of immature T
cells. J Biol Chem. 286:33260–33267. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu F, Wang J, Cao Z, Song M, Fu Y, Zhu Y
and Li Y: cAMP/PKA signaling pathway induces apoptosis by inhibited
NF-κB in aluminum chloride-treated lymphocytes in vitro. Biol Trace
Elem Res. 170:424–431. 2016. View Article : Google Scholar
|
|
35
|
Fatemi A, Kazemi A, Kashiri M and Safa M:
Elevation of cAMP levels inhibits doxorubicin-induced apoptosis in
Pre- B ALL NALM-6 cells through induction of BAD phosphorylation
and inhibition of P53 accumulation. Int J Mol Cell Med. 4:94–102.
2015.PubMed/NCBI
|
|
36
|
Safa M, Mousavizadeh K, Noori S,
Pourfathollah A and Zand H: cAMP protects acute promyelocytic
leukemia cells from arsenic trioxide-induced caspase-3 activation
and apoptosis. Eur J Pharmacol. 736:115–123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cochran BJ, Bisoendial RJ, Hou L, Glaros
EN, Rossy J, Thomas SR, Barter PJ and Rye KA: Apolipoprotein A-I
increases insulin secretion and production from pancreatic β-cells
via a G-protein-cAMP-PKA-FoxO1-dependent mechanism. Arterioscler
Thromb Vasc Biol. 34:2261–2267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vogt PK, Jiang H and Aoki M: Triple layer
control: Phosphorylation, acetylation and ubiquitination of FOXO
proteins. Cell Cycle. 4:908–913. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang B, Gui LS, Zhao XL, Zhu LL and Li
QW: FOXO1 is a tumor suppressor in cervical cancer. Genet Mol Res.
14:6605–6616. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie L, Ritz O, Leithäuser F, Guan H,
Färbinger J, Weitzer CD, Gehringer F, Bruederlein S, Holzmann K,
Vogel MJ, et al: FOXO1 downregulation contributes to the oncogenic
program of primary mediastinal B-cell lymphoma. Oncotarget.
5:5392–5402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hwang KE, Park DS, Kim YS, Kim BR, Park
SN, Lee MK, Park SH, Yoon KH, Jeong ET and Kim HR: Prx1 modulates
the chemosensitivity of lung cancer to docetaxel through
suppression of FOXO1-induced apoptosis. Int J Oncol. 43:72–78.
2013.PubMed/NCBI
|
|
42
|
Marshall AD, Picchione F, Geltink RI and
Grosveld GC: PAX3-FOXO1 induces up-regulation of Noxa sensitizing
alveolar rhabdomyosarcoma cells to apoptosis. Neoplasia.
15:738–748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Binsfeld M, Fostier K, Muller J, Baron F,
Schots R, Beguin Y, Heusschen R and Caers J: Cellular immunotherapy
in multiple myeloma: Lessons from preclinical models. Biochim
Biophys Acta. 1846:392–404. 2014.PubMed/NCBI
|
|
44
|
Witkowska M and Smolewski P: Emerging
immunotherapy and strategies directly targeting B cells for the
treatment of diffuse large B-cell lymphoma. Immunotherapy. 7:37–46.
2015. View Article : Google Scholar : PubMed/NCBI
|
